BioVie Inc Sustainability Reports
BioVie Inc. is a clinical-stage biopharmaceutical company that develops innovative drug therapies to treat neurological and neurodegenerative disorders, such as Alzheimer's and Parkinson's disease, and advanced liver disease.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2016 to 2023
Company Profile
BioVie Inc. is a clinical-stage biopharmaceutical company that develops innovative drug therapies to treat neurological and neurodegenerative disorders, such as Alzheimer's and Parkinson's disease, and advanced liver disease.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
